remynd develops first-in-class oral treatments to restore and preserve neuronal function in patients suffering from age-related neurodegenerative diseases such as Alzheimer’s and Huntington’s disease
remynd develops first-in-class oral treatments to restore and preserve neuronal function in patients suffering from age-related neurodegenerative diseases such as Alzheimer’s and Huntington’s disease.